All
Company news
Industry insights
Press releases
Product updates
Tailored workflows in discovery research: Challenges, benefits, and how to implement them today
Reducing the barriers for immune repertoire research: An in-depth interview with Dr. Felix Breden
ENPICOM secures financing from BOP Capital, BOM Brabant Ventures and brings Dr. Colby Souders on board as a new investor
Simulating adaptive immune receptor repertoire sequencing runs with InSilicoSeq
ENPICOM partners with Erasmus University Medical Center in groundbreaking effort to discover nanobodies against cancer
ENPICOM and Carterra advance antibody screening by integrating biophysical characterization and repertoire sequencing analysis
In pursuit of precision: Validating IGX-Profile against a benchmark Rep-Seq dataset
Navigating the immune repertoire: A deep dive into applications, workflows, and new sequencing chemistries
From sample to discovery: Applications, challenges, and the path ahead in full-service repertoire sequencing
Adopting a user-centered approach to biotech software design and development
Accurate clone annotation for antibody and TCR discovery
ENPICOM secures extended financing from BOP Capital, BOM Brabant Ventures, Nextgen Ventures, and Arches Capital
ENPICOM announces CEO transition
Authentication in the IGX Platform
2022 in review: ENPICOM’s highlights
Efficiently using Amazon Web Services
Strength in numbers: Using next-generation sequencing with display technologies for antibody discovery
Vaccine development innovation & collaboration in action: The Inno4Vac project
The animal side of antibody discovery
ENPICOM receives ISO 27001:2013 certification
Phylogenetic analysis of BCR repertoires: Benefits, challenges, and considerations
Accurate developability assessments of antibody candidates with the IGX Platform
From a great idea to best in class SaaS Platform to improve immunotherapy discovery and development
Experiencing being an intern at ENPICOM
Paul van der Velde joins ENPICOM as Chief Operating Officer and Acting Chief Technology Officer
Meet IGX-Track: Our unique new App for seamless analysis of antibody display data
ENPICOM launches versatile display data analysis solution to accelerate antibody selection while maximizing precision
Genovac further enhances its antibody discovery services with the ENPICOM IGX Platform
ENPICOM increases speed and scalability in antibody discovery with Amazon Web Services (AWS)
ENPICOM secures Series B funding to scale up operations to meet the high demand for its antibody discovery SaaS Platform
2021 highlights: ENPICOM’s year in review
Meet IGX Platform 3.1: More flexibility and control for your seamless Rep-Seq analysis workflow
ENPICOM participates in Inno4vac, a European new public-private partnership to innovate vaccine development
From sample to discovery: Advancing your research with full-service immune repertoire sequencing & analysis
ENPICOM introduces a powerful liability prediction solution to de-risk antibody development
ENPICOM is featured among the top 50 fastest growing Data Science SMEs in the Netherlands
ENPICOM to integrate renowned structural antibody prediction tools developed at the University of Oxford
Empowering research teams: The path to accessible immune repertoire data
Zai Lab selects ENPICOM’s IGX Platform to leverage new NGS-powered antibody discovery workflows
The impact of high-throughput immune repertoire sequencing on the analysis of antibody responses: A conversation with Prof. Gunilla Karlsson Hedestam of Karolinska Institute
Webinar: Understanding the role of B cells in cancer through antibody repertoire analysis
Breaking the UX barrier: Towards user-focused biomedical software
ENPICOM and Viroclinics-DDL receive joint MIT R&D ZH subsidy to accelerate and improve antibody and vaccine discovery and development
ENPICOM joins the MIRIADE consortium
ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery
ENPICOM and MiLaboratories join forces to power better Repertoire Sequencing data management and analysis workflows
ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution
ENPICOM is now a corporate sponsor of The Antibody Society
Single-cell sequencing: Industry trends and developments
University Health Network, Canada’s largest research hospital, selects ENPICOM’s IGX Platform to analyze and manage immune sequencing data
Gaining a deeper understanding of the immune system: A conversation with Prof. Dirk Busch and Dr. Kilian Schober of the Technical University of Munich
Fighting COVID-19 and transforming infectious disease research with immune repertoire sequencing
More data from a single cell: Advancing your immunology research with Repertoire Sequencing
ENPICOM receives a €1.13 million follow-on investment
ENPICOM deepens insights into the immune system enabling faster precision medicine development and pandemic prevention
ENPICOM and Cytura Therapeutics partner on early cancer detection
ENPICOM has been featured as one of the 20 cutting-edge tech companies of 2019
DDL diagnostic laboratory and ENPICOM join forces
ENPICOM launches unique immune sequencing data analysis platform
ENPICOM secures funding round to finalize IGX Platform development
Survey results: European immunotherapy companies have great concerns regarding increasing costs and long development timelines
ENPICOM sets a new standard for B cell receptor repertoire analysis
Towards a predictable combination therapy for multiple cancer types
ENPICOM team wins Microsoft Genomics Hackathon
Scientific poster from UKE/ENPICOM receives award at annual meeting of DGHO
